Results 81 to 90 of about 2,996,041 (224)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 11, Page 2336-2346, November 2026.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Update on neuromyelitis optica: natural history and management

open access: yes, 2012
Panitha Jindahra1,2, Gordon T Plant1,21The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK; 2St Thomas' Hospital, Westminster Bridge Road, London, UKAbstract: Neuromyelitis optica or Devic disease is an inflammatory ...
Jindahra P, Plant GT
core  

Brain MRI Findings in Pediatric-Onset Neuromyelitis Optica Spectrum Disorder

open access: yes, 2019
BACKGROUND AND PURPOSE: Differentiating pediatric-onset neuromyelitis optica spectrum disorder from acute disseminated encephalomyelitis could be challenging, especially in cases presenting with only brain manifestations.
Salama, S.   +14 more
core   +1 more source

A Rare Case of Neuromyelitis Optica Spectrum Disorder Secondary to Primary Sjögren’s Syndrome in an Older Woman

open access: yesPrague Medical Report
Primary Sjögren’s syndrome is an autoimmune disorder that is characterized by lymphocytic infiltration of salivary and lacrimal glands. The extra-glandular manifestations might be arthritis, myalgia, glomerulonephritis, skin rashes, and neurologic ...
Hasan Huseyin Zorlu   +1 more
doaj   +1 more source

Neuromyelitis optica spectrum disorders: An update

open access: yesAnnals of Indian Academy of Neurology, 2015
Recent advances in the understanding of neuromyelitis optica spectrum of disorders (NMOSD) have expanded. Diagnostic criteria have changed over the years. The clinical spectrum of disease manifestations are now understood to include sites outside the spinal cord and optic nerve. A variety of autoimmune diseases may coexist with this disorder.
openaire   +3 more sources

Reframing the Gut–Brain Axis: The Gut Wall as a Neural Immune Interface in Multiple Sclerosis and Autoimmune Neurological Diseases

open access: yesAnnals of Neurology, Volume 100, Issue 5, Page 915-930, November 2026.
Gut wall physiology in multiple sclerosis (MS) and autoimmune neurologic diseases remains underexplored but may span gut barrier dysfunction, enteric glial targeting, mucosal immune dysregulation, and autoimmune targets within the enteric nervous system (ENS).
Federico Montini   +4 more
wiley   +1 more source

Very-late-onset neuromyelitis optica spectrum disorder: a case report and review

open access: yesFrontiers in Neurology
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disorder that causes demyelination within the central nervous system, typically manifesting as symptoms of optic neuritis and myelitis.
Rui-Ting Liu   +4 more
doaj   +1 more source

Neuromyelitis Optica Spectrum Disorder Coinciding with Spinocerebellar Ataxia Type 31

open access: yesCase Reports in Neurology, 2017
We report the unusual case of a 63-year-old man with spinocerebellar ataxia (SCA) type 31 who developed neuromyelitis optica spectrum disorder (NMOSD) 14 years after the onset of cerebellar symptoms.
Yoshiaki Takahashi   +5 more
doaj   +1 more source

Clinically Suspected Tumefactive Demyelination Mimicking a Brain Tumor in a 10‐Year‐Old Boy: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT After cranial surgery, a 10‐year‐old boy developed hand weakness, numbness, and fatigue. MRI showed frontoparietal lesions; biopsy lacked documented demyelination. Symptoms and lesions reportedly improved after methylprednisolone. Tumefactive demyelination was suspected, but discordant laterality, unavailable antibody testing, and brief follow‐
Fatima Aman   +8 more
wiley   +1 more source

Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder [PDF]

open access: yes, 2017
A specific humoral immune response against HERV-W envelope surface (env-su) glycoprotein antigens has been reported in serum of patients with multiple sclerosis (MS).
Caggiu, Elisa   +30 more
core   +1 more source

Home - About - Disclaimer - Privacy